ERS International Congress, Milan 2017

---

COPD biomarkers

Thematic Poster
Chairs: A. Koczulla (Marburg, Germany), A. Løkke (Højbjerg, Denmark), G. Caramori (Messina, Italy), L. Fregonese (London, United Kingdom)

Prevalence and clinical characteristics of asthma-COPD overlap syndrome according to accepted criteria Y. Jo (Seoul, Republic of Korea)
Low Level of  Airway Mucin 2 Predict Severe Exacerbations in Patients with Severe Chronic Obstructive Pulmonary Disease A. Sadigov (Baku, Azerbaijan)
Assessing E-RS to measure symptoms in COPD patients with a reversible component S. Pascoe (King of Prussia, United States of America)
Association between serum YKL-40 and chronic obstructive pulmonary disease Y. Ma (CHENGDU, China)
Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD J. Zhang (Shanghai, China)
Influence of tobacco-smoking on serum level of transforming growth factor (TGF) beta 1 in COPD patients D. Mihailichenko (Dnipropetrovsk, Ukraine)
Impact of long-term oxygen therapy on morphological changes of red blood cells and NT-proBNP level in COPD patients. O. Titova (ST PETERSBURG, Russian Federation)
Elevated BALF PEDF levels are related to disease severity, inflammation and small airway obstruction in COPD patientes M. Chen (Chengdu, China)
Levels of serum amyloid A (SAA) and C-reactive protein (CRP) in stable COPD patients and its relationship with disease severity. D. Mihailichenko (Dnipropetrovsk, Ukraine)
Peripheral Blood Eosinophils as Marker of Sputum Eosinophilia and Outocome of COPD Exacerbation E. Jusufovic (Tuzla, Bosnia and Herzegovina)
Cardiovascular comorbidities in chronic obstructive pulmonary disease patients L. Udrescu (TIMISOARA/TIMIS, Romania)
Blood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPD. S. Toujani Chekki (Tunis, Tunisia)
Procalcitonin as a predictor of pneumonia in patients hospitalized with acute exacerbation of COPD: a prospective observational study E. Titova (Trondheim, Norway)
COPD Phenotypes and Comorbidities O. Mascaró (Vic (Barcelona), Spain)
Inflammatory markers and lipid profile in COPD patients over nine years R. Prudente (BOTUCATU/SP, Brazil)
The impact of smoking on the platelets functional activity in patients with COPD E. Khmel (Dniepropetrovsk, Ukraine)
Evaluation of plasma LL-37 and nuclear factor kappa B (NF-?B) levels in stable chronic obstructive pulmonary disease P. Uysal (istanbul, Turkey)
Prevalence and clinical characteristics of blood eosinophilia in patients with acute exacerbation of chronic obstructive pulmonary disease in China H. Zhou (China)
Association of serum pneumoproteins with clinical course of COPD M. Suzuki (Tokyo, Japan)